Cheng Xiaocheng, Hu Qiongwen, Zhou Changyue, Liu Lin Qiong, Chen Tong, Liu Zengzhang, Tang Xuewen
Department of Cardiology, People's Hospital of Chongqing Banan, Chongqing 401320, China.
Department of Clinical Laboratory, The Third People's Hospital of Chongqing, Chongqing 400014, China.
Int J Cardiol. 2015 Feb 15;181:297-302. doi: 10.1016/j.ijcard.2014.12.002. Epub 2014 Dec 3.
The main purpose of this meta-analysis was to compare the long-term efficacy of cryoballoon ablation (CBA) with irrigated radiofrequency catheter ablation (RFCA) for the treatment of atrial fibrillation (AF).
The Medline, Cochrane Library and Embase Database were searched for clinical studies published up to October 2014. Studies that fulfilled our predefined inclusion criteria were included. The primary clinical outcome was the proportion of patients free from AF (follow-up≥3months), and the secondary clinical outcomes included acute pulmonary vein (PV) isolated rate, fluoroscopy time, procedure time and complications.
After a literature search in the major databases, three randomized controlled trials (RCTs) and eight retrospective trials with a total of 1216 patients were identified. Pool-analysis demonstrated that, as compared RFCA, CBA was associated with a similar proportion of patients free from AF at a mean 16.5months follow-up (66.9% vs 65.1%; relative risk [RR]: 1.01; 95% CI: 0.94 to 1.07, P=0.87). Acute PV isolation rate (RR: 0.92; 95% CI: 0.82 to 1.03) and fluoroscopy time (weighted mean difference WMD: -8.60; 95% CI: -18.29 to 3.69) were not statistically significant difference. The procedure time was shorter in CBA group ([WMD]: -31.94; 95% CI: -60.43 to -3.45). Transient phrenic nerve palsy was uniquely observed in the CBA group (5.4%, P<0.00001) and resolved in all during the follow-up period, total complication was similar in both groups (RR: 1.30; 95% CI: 0.91 to 1.85).
CBA was as effective as RFCA for the treatment of atrial fibrillation during long-term follow-up with comparable procedural features.
本荟萃分析的主要目的是比较冷冻球囊消融术(CBA)与灌注射频导管消融术(RFCA)治疗心房颤动(AF)的长期疗效。
检索Medline、Cochrane图书馆和Embase数据库中截至2014年10月发表的临床研究。纳入符合我们预先定义的纳入标准的研究。主要临床结局是无房颤患者的比例(随访≥3个月),次要临床结局包括急性肺静脉(PV)隔离率、透视时间、手术时间和并发症。
在主要数据库中进行文献检索后,确定了三项随机对照试验(RCT)和八项回顾性试验,共1216例患者。汇总分析表明,与RFCA相比,在平均16.5个月的随访中,CBA组无房颤患者的比例相似(66.9%对65.1%;相对风险[RR]:1.01;95%可信区间:0.94至1.07,P=0.87)。急性PV隔离率(RR:0.92;95%可信区间:0.82至1.03)和透视时间(加权平均差WMD:-8.60;95%可信区间:-18.29至3.69)无统计学显著差异。CBA组的手术时间较短([WMD]:-31.94;95%可信区间:-60.43至-3.45)。CBA组唯一观察到短暂性膈神经麻痹(5.4%,P<0.00001),且在随访期间均恢复,两组的总并发症相似(RR:1.30;95%可信区间:0.91至1.85)。
在长期随访中,CBA治疗心房颤动的效果与RFCA相当,手术特征相似。